placeholder

Online Conference 30.07.2020
 10:00 AM Central European Summer Time (CEST)

Awareness for good practices on antimicrobial usage to safeguard One Health and the impact of the new veterinary regulation

Afterthoughs

In the race against antimicrobial resistance the balance has shifted from ignorance to ineptitude. A misapprehension of the modern applications in veterinary medicine could jeopardize scientific endeavours to resolve antimicrobial resistance. What might be the consequences of the new Veterinary Medicinal Products Regulation on the one health approach? What solutions do we have today to improve antibiotic usage? 

1st EVAC's program

Antibiotic resistance is a significant issue. Unfortunately, today the only emphasis is set on antimicrobial reduction instead of correct usage. At this moment Colistin is again subject to be banned based on questionable criteria. Moreover, correct usage of antibiotics can reduce to even eliminate the risk of selecting for antimicrobial resistance. This is relevant not only for novel antibiotics but also for generic compounds.


The misconception on antimicrobial resistance

The example of Colistin

Critical view on antimicrobial developments

Antimicrobials 
Are the recommendations for the future still relevant?

"In a philosophy of limits, calculated ignorance and risk, he who cannot know everything has no right to ban everything"

- Albert Camus (nobel prize in Literature, 1957) -

Speakers

placeholder

Pascal Richez
DVM, DSc, DipECVPT

Thirty years of experience within the animal and human pharmaceutical industry as director of toxicology and/or general pharmacology departments or as Consultant for major pharmaceutical/feed additives companies or national firms. Supervision of hundreds of R&D projects, leading to Approval by regulatory authorities of a number of new products currently on the market (feed additives, veterinary drugs, biocidal products).  

placeholder

Xavier Chatenet
DVM, Field practitioner

Dr. Chatenet is a veterinarian and bird expert with more than two decades of field experience. Between 2010 and 2019 he travelled the world to give seminars and trainings to avail poultry health and improve management practices. The past six months Dr. Chatenet devoted his time to bring practical insights to the pharmaceutical industry and initiated the development of a field test to detect for resistance genes in bacteria.

placeholder

Dr. Boudewijn Catry
Head Healthcare associated Infections & antimicrobial resistance (Belgium Gov)
Ass. Prof Epidemiology - ULB

Dr. Boudewijn Catry (DVM °2000, PhD °2005) is a researcher with a special interest in antimicrobial resistance, both in veterinary and human medicine. Between 2000 and 2007, he combined ambulatory practice & obstetrics as a veterinary surgeon with laboratory research at the Ghent University (Ugent). Hereafter he started to work at Sciensano where he is since 2009 in charge of the service Healthcare associated Infections & Antimicrobial Resistance (www.nsih.be). He is involved in national and international committees on the prudent use of antimicrobials and infection prevention. He is co-founder (°2013) of the outbreak support team for multidrug resistant organisms in Belgian hospitals (MDRO-OST). Since 2018 he is lecturer epidemiology at the Faculty of Medicine in Brussels (Université libre de Bruxelles,ULB). 

register


Organized by

placeholder

For more information: webinar@evac2020.be

All rights reserved: 2020 © Inovet Group

Website made and created by: Inovet

placeholder
Cookies